Skip to main content
logo
Prostatype Genomics AB (publ) (STO:PROGEN)
Sweden flag Sweden · Delayed Price · Currency is SEK
0.1220
+0.0065 (5.63%)
Sep 25, 2026, 5:29 PM CET

Prostatype Genomics AB Financials Overview

Millions SEK. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
0.810.590.21.360.680.01
Revenue Growth
35.52%198.49%-85.32%98.54%6729.32%-99.23%
Gross Profit
-17.15-20.2-22.16-18.48-12.81-8.48
Operating Income
-37.46-38.94-40.85-39.25-28.69-15.55
Net Income
-37.9-44.5-41.05-41.44-29.09-15.63
Earnings Per Share
-0.69-1.32-29.10-512.68-1597.92-1105.51
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
0.399.079.422.6811.4920.33
Total Debt
-5.30.0711.670.871.27
Net Cash (Debt)
0.393.779.35-8.9910.6219.06
Net Cash Growth
-89.60%-59.71%---44.28%32.42%
Net Cash Per Share
0.010.116.63-111.17583.531348.32

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-20.9-23.8-44.71-29.14-27.69-16.08
Capital Expenditures
-0.06-0.26-0.29-0.08--
Free Cash Flow
-20.96-24.06-44.99-29.21-27.69-16.08
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Margin
-4653.29%-6555.22%-20529.65%-2894.32%-4200.44%-155467.10%
Pretax Margin
-4708.45%-7492.09%-20628.64%-3055.68%-4258.71%-156281.95%
Profit Margin
-4708.45%-7492.09%-20628.64%-3055.68%-4258.71%-156281.95%
FCF Margin
-2603.48%-4050.34%-22610.05%-2154.35%-4054.61%-160766.02%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
84.8829.89373.998.3770.9513487.32